| Ssm Health St. Mary's Hospital-madison | |
|
700 S. Park St. Madison WI 53715-1830 | |
| (608) 251-6100 | |
| (608) 258-5221 |
| Full Name | Ssm Health St. Mary's Hospital-madison |
|---|---|
| Speciality | General Acute Care Hospital |
| Location | 700 S. Park St., Madison, Wisconsin |
| Authorized Official Name and Position | Joseph Minerath (SYSTEM DIR OF GOV REIMBURSEMENT) |
| Authorized Official Contact | 6082586891 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ssm Health St. Mary's Hospital-madison 700 S. Park St. Madison WI 53715-1830 Ph: (608) 251-6100 | Ssm Health St. Mary's Hospital-madison 700 S. Park St. Madison WI 53715-1830 Ph: (608) 251-6100 |
| NPI Number | 1184621211 |
|---|---|
| Provider Enumeration Date | 07/05/2005 |
| Last Update Date | 04/08/2024 |
| Medicare PECOS PAC ID | 8527977867 |
|---|---|
| Medicare Enrollment ID | O20031208000247 |
News Archive
TAXIS Pharmaceuticals, Inc. (TAXIS), Rutgers, The State University of New Jersey, and the University of Medicine and Dentistry of New Jersey (UMDNJ) have entered into an exclusive licensing agreement for worldwide rights to develop and commercialize a novel antimicrobial technology addressing multidrug-resistant (MDR) bacterial infections.
Proteros Biostructures GmbH announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under which Proteros will provide structure-based drug discovery services to IP-K.
Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes surrounding the spinal cord and brain. Cases of LMC have increased because of the improved survival of lung cancer patients with the help of new advances in treatment.
Admedus today announced that interim study results on its Phase 1 trial of a therapeutic vaccine for Herpes Simplex Virus (HSV-2) have shown that it achieved the primary endpoint of the study by being safe in the study subjects. In addition, the study has also shown that the vaccine was able to generate a T-cell response.
Emerging evidence on the development, "prodromal" characteristics, and long-term course of schizophrenia provide reasons for optimism for developing new treatments and preventive approaches for this devastating disorder, according to the special March/April issue of Harvard Review of Psychiatry.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184621211 | NPI | - | NPPES |
| 39080639301 | Other | WI | UNITY PROVIDER NUMBER |
| 390806393026 | Other | WI | BLUE CROSS PROVIDER NUMBE |
| 390806393 | Other | WI | INS PROVIDER NUMBER |
| 5283846 | Other | WI | MEDICA PROVIDER NUMBER |
| 11022900 | Medicaid | WI | |
| A5371501 | Other | WI | JOHN DEERE PROVIDER NUMBE |
| 5389107 | Other | WI | PHYSICIANS PLUS PROVIDER |
| 67 | Other | WI | DEANCARE PROVIDER NUMBER |
News Archive
TAXIS Pharmaceuticals, Inc. (TAXIS), Rutgers, The State University of New Jersey, and the University of Medicine and Dentistry of New Jersey (UMDNJ) have entered into an exclusive licensing agreement for worldwide rights to develop and commercialize a novel antimicrobial technology addressing multidrug-resistant (MDR) bacterial infections.
Proteros Biostructures GmbH announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under which Proteros will provide structure-based drug discovery services to IP-K.
Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes surrounding the spinal cord and brain. Cases of LMC have increased because of the improved survival of lung cancer patients with the help of new advances in treatment.
Admedus today announced that interim study results on its Phase 1 trial of a therapeutic vaccine for Herpes Simplex Virus (HSV-2) have shown that it achieved the primary endpoint of the study by being safe in the study subjects. In addition, the study has also shown that the vaccine was able to generate a T-cell response.
Emerging evidence on the development, "prodromal" characteristics, and long-term course of schizophrenia provide reasons for optimism for developing new treatments and preventive approaches for this devastating disorder, according to the special March/April issue of Harvard Review of Psychiatry.
› Verified 1 days ago
Oriel Medicine S.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5231 University Ave, Madison, WI 53705 Phone: 608-238-0100 Fax: 608-238-7550 | |
Out Health Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5231 University Ave, Madison, WI 53705 Phone: 608-238-0100 Fax: 608-238-7550 | |
Steinhauer Family Eye Clinic, S.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2639 University Ave, Madison, WI 53705 Phone: 608-255-6407 Fax: 608-255-1889 | |
Therapy Space Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 740 Regent St Ste 202, Madison, WI 53715 Phone: 608-572-2101 | |
Ac Medical Center Or Acmc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1421 S Park St, Madison, WI 53715 Phone: 608-441-6888 Fax: 608-441-6888 | |
Concentra Urgent Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4260 E Towne Blvd, Madison, WI 53704 Phone: 608-244-1213 Fax: 608-244-5508 | |
Unitypoint Health - Meriter Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-417-6000 |